Terms: = Lung cancer AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Prognosis
47 results:
1. Association of log odds of positive lymph nodes with survival in patients with small cell lung cancer: Results from the SEER database.
Gao T; Chang Y; Yue H
Clinics (Sao Paulo); 2024; 79():100369. PubMed ID: 38696974
[TBL] [Abstract] [Full Text] [Related]
2. Treatment sequencing after failure to alectinib in patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer.
Shimomura Y; Sawa K; Imai T; Ihara Y; Yoshida H; Shintani A
Cancer Sci; 2024 Mar; 115(3):926-936. PubMed ID: 38148717
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic factors and novel nomograms for overall survival and cancer specific survival of malignant ovarian cancer patients with bone metastasis: A SEER-based study.
Luo L; Xu N; Liu Y; Zhong S; Yang S; Chen X
Int J Gynaecol Obstet; 2024 Apr; 165(1):176-187. PubMed ID: 38013509
[TBL] [Abstract] [Full Text] [Related]
4. Development and validation of a prognostic nomogram for patients with laryngeal cancer with synchronous or metachronous lung cancer.
Su H; Li H; Hou S; Song X; Zhang X; Wang W; Li Z
Head Neck; 2024 Jan; 46(1):177-191. PubMed ID: 37930037
[TBL] [Abstract] [Full Text] [Related]
5. Time-course transcriptome analysis of a double challenge bleomycin-induced lung fibrosis rat model uncovers ECM homoeostasis-related translationally relevant genes.
Bonatti M; Pitozzi V; Caruso P; Pontis S; Pittelli MG; Frati C; Mangiaracina C; Lagrasta CAM; Quaini F; Cantarella S; Ottonello S; Villetti G; Civelli M; Montanini B; Trevisani M
BMJ Open Respir Res; 2023 Sep; 10(1):. PubMed ID: 37730279
[TBL] [Abstract] [Full Text] [Related]
6. Nomograms for predicting overall survival in colorectal cancer patients with metastasis to the liver, lung, bone, and brain.
Wang H; Shan X; Zhang M; Qian K; Shen Z; Zhou W
Cancer Causes Control; 2023 Dec; 34(12):1059-1072. PubMed ID: 37486401
[TBL] [Abstract] [Full Text] [Related]
7. Relationship between hemoglobin and lung cancer: evidence from Mendelian randomization and National Health and Nutrition Examination Survey.
Dong P; Li W; Deng J; Huang L; Liu B; Wang S; Xu X; Su Y; Lin Z; Li S; Gu J; Qiu Y; Zhou Y
Clin Transl Oncol; 2024 Mar; 26(3):623-629. PubMed ID: 37477785
[TBL] [Abstract] [Full Text] [Related]
8. [Prognostic factors for non-small cell lung cancer patients with central nervous system metastasis with positive driver genes].
Li R; Zhang SR; Liu XF; Zhang JW; Zhao JY; Bai P; Zhang XC
Zhonghua Yi Xue Za Zhi; 2023 Apr; 103(16):1202-1209. PubMed ID: 37087403
[No Abstract] [Full Text] [Related]
9. Nomogram to predict the prognosis of patients with AFP-negative hepatocellular carcinoma undergoing chemotherapy: A SEER based study.
Wang L; Peng JL; Wu JZ
Medicine (Baltimore); 2023 Mar; 102(13):e33319. PubMed ID: 37000113
[TBL] [Abstract] [Full Text] [Related]
10. Integrated glycomics strategy for galactosylated-N-glycans recognized by Bandeiraea Simplicifolia Lectin I in salivary proteins associated with lung cancer.
Zhang F; Xie M; Tang Z; Xie H; Yue L; Wang X; Yang J; Chen Y; Li Z
Proteomics Clin Appl; 2023 May; 17(3):e2200012. PubMed ID: 36349801
[TBL] [Abstract] [Full Text] [Related]
11. [Effect of CD4-positive T lymphocyte expression rate on pain control and prognosis in stage Ⅳ non-small cell lung cancer patients with cancerous pain].
Chen H; Guo DP; Liu C; Wu GH; Li YW; Fan BF; Xie GL
Zhonghua Yi Xue Za Zhi; 2022 Oct; 102(39):3110-3114. PubMed ID: 36274594
[No Abstract] [Full Text] [Related]
12. Integrative Analysis of Pyroptosis-Related Prognostic Signature and Immunological Infiltration in lung Squamous Cell Carcinoma.
Luo P; Jiang Y; Ding S; Jiang S; Tang R; Tang Z
Biomed Res Int; 2022; 2022():4944758. PubMed ID: 35692583
[TBL] [Abstract] [Full Text] [Related]
13. Comprehensive Analysis of Prognostic and Immune Infiltrates for RAD51 in Human Breast cancer.
Li F; Zhang Y; Shi Y; Liu S
Crit Rev Eukaryot Gene Expr; 2021; 31(4):71-79. PubMed ID: 34587437
[TBL] [Abstract] [Full Text] [Related]
14. The D-dimer level predicts the prognosis in patients with lung cancer: a systematic review and meta-analysis.
Ma M; Cao R; Wang W; Wang B; Yang Y; Huang Y; Zhao G; Ye L
J Cardiothorac Surg; 2021 Aug; 16(1):243. PubMed ID: 34454552
[TBL] [Abstract] [Full Text] [Related]
15. Clinicopathological, gene expression and genetic features of stage I lung adenocarcinoma with necrosis.
Oiwa H; Aokage K; Suzuki A; Sato K; Kuroe T; Mimaki S; Tane K; Miyoshi T; Samejima J; Tsuchihara K; Goto K; Funai K; Tsuboi M; Nakai T; Ishii G
Lung Cancer; 2021 Sep; 159():74-83. PubMed ID: 34311347
[TBL] [Abstract] [Full Text] [Related]
16. RMI2 is a prognostic biomarker and promotes tumor growth in hepatocellular carcinoma.
Li Y; He X; Zhang X; Xu Y; Chen W; Liu X; Xu X
Clin Exp Med; 2022 May; 22(2):229-243. PubMed ID: 34275027
[TBL] [Abstract] [Full Text] [Related]
17. Molecular identification of an immunity- and Ferroptosis-related gene signature in non-small cell lung cancer.
Liu T; Luo H; Zhang J; Hu X; Zhang J
BMC Cancer; 2021 Jul; 21(1):783. PubMed ID: 34229636
[TBL] [Abstract] [Full Text] [Related]
18. Lymphangiosis carcinomatosa independently affects long-term survival of Non-Small Cell lung cancer patients.
Heldwein MB; Doerr F; Schlachtenberger G; Menghesha H; Kuhn EW; Scheel AH; Michel M; Wahlers T; Hekmat K
Surg Oncol; 2021 Jun; 37():101611. PubMed ID: 34090103
[TBL] [Abstract] [Full Text] [Related]
19. New insights into patterns of first metastatic sites influencing survival of patients with hormone receptor-positive, HER2-negative breast cancer: a multicenter study of 271 patients.
Yamamura J; Kamigaki S; Fujita J; Osato H; Manabe H; Tanaka Y; Shinzaki W; Hashimoto Y; Komoike Y
BMC Cancer; 2021 Apr; 21(1):476. PubMed ID: 33926418
[TBL] [Abstract] [Full Text] [Related]
20. [CD45RO⁺ Memory T Lymphocytes As A Candidate Marker for Non-small Cell lung cancer].
Tan Q; Li H; Yu M; Tang X; Tan J; Zhang S; Wang J
Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):254-264. PubMed ID: 33910273
[TBL] [Abstract] [Full Text] [Related]
[Next]
